Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME.
Saved in:
| Title: | Cetuximab combined with paclitaxel or paclitaxel alone for patients with recurrent or metastatic head and neck squamous cell carcinoma progressing after EXTREME. |
|---|---|
| Authors: | Chevalier, Thomas1 (AUTHOR) thomas.chevalier@ap-hm.fr, Daste, Amaury2 (AUTHOR), Saada‐Bouzid, Esmaa3 (AUTHOR), Loundou, Anderson4 (AUTHOR), Peyraud, Florent2 (AUTHOR), Lambert, Tiphaine5 (AUTHOR), Le Tourneau, Christophe5 (AUTHOR), Peyrade, Frédéric3 (AUTHOR), Dupuis, Charlotte1 (AUTHOR), Alfonsi, Marc6 (AUTHOR), Fayette, Jérôme7 (AUTHOR), Reure, Juliette7 (AUTHOR), Huguet, Florence8 (AUTHOR), Fakhry, Nicolas9 (AUTHOR), Toullec, Clémence10 (AUTHOR), Salas, Sébastien1 (AUTHOR) |
| Source: | Cancer Medicine. May2021, p1. 12p. 4 Illustrations, 3 Charts. |
| Database: | Academic Search Ultimate |
| ISSN: | 20457634 |
|---|---|
| DOI: | 10.1002/cam4.3953 |
